Prognostic Value of Serum Tenascin-C Levels on Long-Term Outcome After Acute Myocardial Infarction
- 29 March 2012
- journal article
- Published by Elsevier BV in Journal of Cardiac Failure
- Vol. 18 (6), 480-486
- https://doi.org/10.1016/j.cardfail.2012.02.009
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Utility of Cardiac Biomarkers in Predicting Infarct Size, Left Ventricular Function, and Clinical Outcome After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial InfarctionКАРДИОЛОГИЯ УЗБЕКИСТАНА, 2008
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart FailureClinical Biochemistry, 2008
- Cardiac Troponin T at 96 Hours After Acute Myocardial Infarction Correlates With Infarct Size and Cardiac FunctionJournal of the American College of Cardiology, 2006
- Matrix Metalloproteinase-9 Is a Marker of Heart Failure After Acute Myocardial InfarctionJournal of Cardiac Failure, 2006
- Plasma Level of B-Type Natriuretic Peptide as a Prognostic Marker After Acute Myocardial InfarctionCirculation, 2004
- B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial InfarctionCirculation, 2003
- Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trialsThe Lancet, 2003
- The Extracellular Matrix and the Cytoskeleton in Heart Hypertrophy and FailureHeart Failure Reviews, 2000
- C-Reactive Protein as a Predictor of Infarct Expansion and Cardiac Rupture After a First Q-Wave Acute Myocardial InfarctionCirculation, 1997
- Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.Circulation, 1990